SCHEMBL13637014

SCHEMBL13637014

COC(=O)c1ncncc1NC(=O)OC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
EGFR P00533 2/20 0.36
KDR P35968 2/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35
TUBA3C P0DPH7 2/20 0.35
TUBA1B P68363 2/20 0.35
TUBA4A P68366 2/20 0.35
TUBB4B P68371 2/20 0.35
TUBB3 Q13509 2/20 0.35
TUBB2A Q13885 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27957867 0.77 NPSR1 (0.42) HPGDCYP1A2CYP2C19KDM4EALOX15
SCHEMBL27537457 0.72 HPGD (0.45) HPGDNPC1CYP1A2CYP2D6CYP2C9
SCHEMBL4774522 0.71 HPGD (0.43) HPGDNPC1CYP1A2CYP2D6CYP2C9
SCHEMBL4772581 0.70 HPGD (0.42) HPGDNPC1CYP1A2CYP2D6CYP2C9
SCHEMBL14145729 0.70 HPGD (0.42) HPGDNPC1CYP1A2CYP2D6CYP2C9
SCHEMBL30143994 0.70 NPSR1 (0.45) KDM4ENPSR1L3MBTL1CSNK2A1ALDH1A1
SCHEMBL13943352 0.70 NPSR1 (0.45) KDM4ENPSR1L3MBTL1CSNK2A1ALDH1A1
SCHEMBL28026566 0.69 L3MBTL1 (0.57) HPGDRAB9ASMN1; SMN2KDM4EALOX15
SCHEMBL4765220 0.69 MAPK8 (0.45) HPGDNPC1CYP1A2CYP2D6CYP2C9
SCHEMBL14145705 0.69 HPGD (0.41) HPGDNPC1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606255-B1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2009-11-11 EP disclosed